API

Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…

Summary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…

KEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…

Introduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…

Keypoints                                                                                                                                                              Dr. Reddy’s Laboratories said it has received approval from the US health regulator to market Lenalidomide capsules, used to treat multiple…

Key points:  India’s Everest Organics starts manufacturing Molnupiravir Active Pharmaceutical ingredient (API) for Merck’s COVID-19 pill. Everything you need to know about…

US FDA’s Center for Drug Evaluation and Research (CDER) – Novel Drug Approvals for 2021 Innovation drives progress. When it comes to…

Ind-Swift Laboratories will sell its Active Pharmaceutical Ingredients (API) business to PI Industries for an enterprise value of Rs 1,530 crore. The sale is expected…